Kimberly-Clark Corporation $KMB Shares Sold by New England Research & Management Inc.

New England Research & Management Inc. lowered its position in shares of Kimberly-Clark Corporation (NASDAQ:KMB) by 44.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,913 shares of the company’s stock after selling 8,775 shares during the period. New England Research & Management Inc.’s holdings in Kimberly-Clark were worth $1,063,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in KMB. Edmond DE Rothschild Holding S.A. purchased a new position in Kimberly-Clark during the 2nd quarter worth approximately $32,000. Ancora Advisors LLC acquired a new position in Kimberly-Clark during the second quarter worth approximately $32,000. Clearstead Trust LLC purchased a new stake in Kimberly-Clark in the second quarter valued at approximately $33,000. Markowski Investments purchased a new stake in Kimberly-Clark in the second quarter valued at approximately $36,000. Finally, Avalon Trust Co purchased a new stake in Kimberly-Clark in the second quarter valued at approximately $37,000. 76.29% of the stock is owned by hedge funds and other institutional investors.

Kimberly-Clark Stock Performance

KMB stock traded up $1.50 during trading on Friday, hitting $105.57. The company had a trading volume of 4,353,781 shares, compared to its average volume of 4,517,686. The firm has a market cap of $35.11 billion, a PE ratio of 17.95, a price-to-earnings-growth ratio of 5.32 and a beta of 0.25. Kimberly-Clark Corporation has a 1-year low of $92.42 and a 1-year high of $123.09. The firm has a 50-day moving average price of $102.77 and a 200-day moving average price of $102.61. The company has a quick ratio of 0.69, a current ratio of 0.91 and a debt-to-equity ratio of 3.45.

Kimberly-Clark (NASDAQ:KMB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 EPS for the quarter, missing the consensus estimate of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The company had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.22 billion. During the same period in the prior year, the company earned $1.92 earnings per share. The firm’s revenue was up .6% on a year-over-year basis. On average, analysts expect that Kimberly-Clark Corporation will post 7.35 earnings per share for the current year.

Kimberly-Clark Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 2nd. Stockholders of record on Friday, September 4th were paid a dividend of $1.28 per share. This represents a $5.12 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Friday, September 4th. Kimberly-Clark’s dividend payout ratio is 87.07%.

Key Stories Impacting Kimberly-Clark

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: Preliminary earnings beat expectations: Kimberly-Clark expects third-quarter adjusted EPS of $1.70, ahead of the $1.58 FactSet consensus. The result was achieved despite lower sales, supporting the view that cost controls and operational improvements are helping protect profitability. Reuters preliminary results article
• Positive Sentiment: 2026 outlook reaffirmed: Management maintained its full-year financial outlook, including organic sales growth expected to be approximately 100 basis points below weighted-average category growth. The absence of a guidance reduction appears to have reassured investors following the weaker sales environment. Kimberly-Clark preliminary results release
• Positive Sentiment: Price target increased: BNP Paribas Exane raised its KMB target from $101 to $110 while maintaining a neutral rating. The target implies modest upside from the current trading level, providing some valuation support but not signaling strong conviction. Benzinga price target report
• Neutral Sentiment: China-related legal issue: Reports indicate China cleared claims involving formamide, potentially reducing a regulatory and litigation overhang. However, the broader commercial impact of the controversy remains uncertain. Reuters China claims article
• Negative Sentiment: Sales and dividend concerns persist: Kimberly-Clark forecast a third-quarter sales decline following a social-media backlash in China. Separate coverage warned that the company’s long dividend-growth streak is under pressure as profits shrink, despite free cash flow still covering payouts. Wall Street Journal sales outlook article

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on KMB. Wells Fargo & Company lowered their target price on shares of Kimberly-Clark from $105.00 to $100.00 and set an “equal weight” rating on the stock in a research report on Monday, October 5th. Barclays lifted their target price on shares of Kimberly-Clark from $101.00 to $115.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Freedom Capital upgraded shares of Kimberly-Clark from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 4th. BNP Paribas Exane increased their price target on shares of Kimberly-Clark from $101.00 to $110.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Weiss Ratings upgraded shares of Kimberly-Clark from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Kimberly-Clark presently has an average rating of “Hold” and an average price target of $116.50.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation (NASDAQ:KMB) is a global personal care and consumer products company that develops and markets essential products for consumers and professional customers. Its portfolio includes products in the baby and childcare, adult care, feminine care, facial and bathroom tissue, and household categories.

The company’s well-known brands include Huggies diapers and wipes, Kleenex tissues, Kotex feminine care products, Cottonelle and Scott bathroom tissue, and Depend and Poise adult care products.